Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to -$170000.0.

  • Sight Sciences' Cash from Investing Activities fell 23333.33% to -$170000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$517000.0, marking a year-over-year decrease of 97.66%. This contributed to the annual value of -$385000.0 for FY2024, which is 5132.74% up from last year.
  • Sight Sciences' Cash from Investing Activities amounted to -$170000.0 in Q3 2025, which was down 23333.33% from -$210000.0 recorded in Q2 2025.
  • Sight Sciences' Cash from Investing Activities' 5-year high stood at -$51000.0 during Q3 2024, with a 5-year trough of -$342000.0 in Q2 2022.
  • For the 5-year period, Sight Sciences' Cash from Investing Activities averaged around -$185500.0, with its median value being -$163500.0 (2021).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first surged by 8322.37% in 2024, then tumbled by 23333.33% in 2025.
  • Quarter analysis of 5 years shows Sight Sciences' Cash from Investing Activities stood at -$157000.0 in 2021, then rose by 17.83% to -$129000.0 in 2022, then tumbled by 104.65% to -$264000.0 in 2023, then skyrocketed by 48.11% to -$137000.0 in 2024, then decreased by 24.09% to -$170000.0 in 2025.
  • Its Cash from Investing Activities stands at -$170000.0 for Q3 2025, versus -$210000.0 for Q2 2025 and -$137000.0 for Q4 2024.